HIV is epidemic in Ukraine and at the end of 2017, the total official number was reported to be 42700 cases. Approximately, 90% of HIV positive patients develop various types of skin diseases. Especially, patients with psoriasis and HIV infection often present with more severe and treatment-refractory cutaneous disease. We describe a patient with first manifestation of pustular psoriasis with previously unknown HIV infection. A 35 years-old male was admitted to our clinic with severe pustular psoriasis eruption which first emerged two months ago. The patient?s HIV antibody test was positive. Psoriasis manifestations can be severe in patients with acquired immune deficiency syndrome (AIDS). Physicians may face diagnostic and therapeutic difficulties when psoriasis coexists with HIV infection. The HIV test should be considered in patients affected by severe erythrodermic psoriasis and resistant to conventional and biological treatments.
Keywords: Pustular psoriasis; HIV infection; AIDS
Ukrayna'da insan immün yetmezlik virüsü (HIV) epidemik olup, 2017 yılının başında resmi olarak açıklanan toplam sayı 42700 vakadır. HIV pozitif olan hastaların yaklaşık %90'ında bazı deri hastalıkları gelişir. Özellikle HIV enfeksiyonu bulunan hastalarda, psöriyazis daha ciddi ve tedaviye dirençli bir deri hastalığı olarak karşımıza çıkar. Burada, ilk kez püstüler psöriyazis tanısı alan ve daha önce HIV pozitifliği bilinmeyen bir hastanın vaka sunumunu yaptık. Otuzbeş yaşında erkek hasta kliniğimize 2 ay önce ilk kez ortaya çıkan ciddi püstüler psöriyazis nedeniyle başvurdu, HIV antikor testi sonucu pozitif olarak gelen hastanın HIV pozitifliğinden daha önce haberi olmadığı öğrenildi. Edinsel immün yetmezlik sendromlu hastalarda psöriyazis ciddi seyirli olabildiği gibi, klinisyenler tanıda ve tedavide HIV enfeksiyonu ile birlikte bulunan psöriyazis hastalarında zorluklarla karşılaşabilirler. Bu vaka dolayısıyla HIV araştırılmasının özellikle ciddi, eritrodermik, konvansiyonel ve biyolojik tedavilere dirençli vakalarda önemini vurgulamak istedik.
Anahtar Kelimeler: Psöriyazis; HIV; Edinilmiş immünyetmezlik sendromu
- Guerreiro de Moura CA, de Assis LH, Góesa P, Rosad F, Nunes V, Gusmão IM, et al. A case of acute generalized pustular psoriasis of von Zumbusch Triggered by Hypocalcemia. Case Rep Dermatol. 2015;7(3):345-51. [Crossref] [PubMed] [PMC]
- Trent JT, Kerdel FA. Successful treatment of von Zumbusch pustular psoriasis with infliximab. J Cutan Med Surg. 2004;8(4):224-8. [Crossref] [PubMed]
- Mikhail M, Weinberg JM, Smith BL. Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus. Arch Dermatol. 2008;144(4):453-6. [Crossref] [PubMed]
- Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol. 2014;70(3):512-6. [Crossref] [PubMed]
- Duvic M, Johnson TM, Rapini RP, Freese T, Brewton G, Rios A. Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome. Arch Dermatol. 1987;123(12):1622-32. [Crossref] [PubMed]
- Mallon E, Bunker CB. HIV-associated psoriasis. AIDS Patient Care STDS. 2000;14(5):239-46. [Crossref] [PubMed]
- Morar N, Willis-Owen SA, Maurer T, Bunker CB. HIV-associated psoriasis: pathogenesis, clinical features, and management. Lancet Infect Dis. 2010;10(7):470-8. [Crossref]
- Ceccarelli M, Venanzi Rullo E, Vaccaro M, Facciolà A, d'Aleo F, Paolucci IA, et al. HIV-associated psoriasis: Epidemiology, pathogenesis, and management. Dermatol Ther. 2019;32(2):e12806. [Crossref] [PubMed]
- Valenzuela F, Fernández J, Sánchez M, Zamudio A. Erythrodermic psoriasis and human immunodeficiency virus: association and therapeutic challenges. An Bras Dermatol. 2018;93(3):438-40. [Crossref] [PubMed] [PMC]
- Alpalhão M, Borges-Costa J, Filipe P. Psoriasis in HIV infection: an update. Int J STD & AIDS. 2019;30(6):596-604. [Crossref] [PubMed]
- Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377-85. [Crossref] [PubMed]
- Zhang Z, Xu JH. Investigation of psoriasis susceptibility loci in psoriatic arthritis and a generalized pustular psoriasis cohort. J Investig Dermatol Symp Proc. 2018;19(2):S83-5. [Crossref] [PubMed]
- Teraki Y, Tanaka S, Hitomi K, Izaki S. A case of generalized psoriasiform and pustular eruption induced by infliximab: evidence for skin-homing Th17 in the pathogenesis. Br J Dermatol. 2010;163(6):1347-51. [Crossref] [PubMed]
- Onoufriadis A, Simpson MA, Pink AE, Di Meglio P, Smith CH, Pullabhatla V, et al. Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am J Hum Genet. 2011;89(3):432-7. [Crossref] [PubMed] [PMC]
- Marrakchi S, Guigue P, Renshaw BR, Puel A, Pei XY, Fraitag S, et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med. 2011;365(7):620-8. [Crossref] [PubMed]
- Mu-oz-Pérez MA, Rodriguez-Pichardo A, Camacho F, Colmenero MA. Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3-year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse. Br J Dermatol. 1998;139(1):33-9. [Crossref] [PubMed]
- The Public Health Center of the Ministry of Health of Ukraine [Statistical Reference for HIV/AIDS]. 2018 Kyiv, Ukrainian: MOZ2016; 2018. Available from: http://ucdc.gov.ua/ pages/diseases/hiv_aids/statistics/hiv-aids-treatment.
- Duvic M. Immunology of AIDS related to psoriasis. J Invest Dermatol. 1990;95(5 Suppl):38S-40S. [Crossref] [PubMed]
- Gudjonsson JE, Elder JT. Psoriasis. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, eds. Fitzpatrick's Dermatology in General Medicine. 8th ed. Vol 22. New York: McGraw-Hill; 2012. p.197-231.
- lizuka H, Takahashi H, Ishida-Yamamoto A. Pathophysiology of generalized pustular psoriasis. Arch Dermatol Res. 2003;295 Suppl 1:S55-9. [Crossref] [PubMed]
- Drexler AM. Tumor necrosis factor: its role in HIV/AIDS. STEP Perspect. 1995;7(1):13-5.
.: Process List